These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10423999)
1. [The atherogenesis characteristics of diabetic patients]. Prystupiuk OM Lik Sprava; 1999; (1):57-9. PubMed ID: 10423999 [TBL] [Abstract][Full Text] [Related]
2. [The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics]. Krasil'nikova EI; Freĭdlin IS Patol Fiziol Eksp Ter; 1991; (4):41-3. PubMed ID: 1798652 [TBL] [Abstract][Full Text] [Related]
3. [Immunological aspects of diabetic angiopathies pathogenesis]. Galenok VA; Zhuk EA Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794 [No Abstract] [Full Text] [Related]
4. [HLD-cholesterol and LDL-cholesterol in the blood in type I and II diabetes mellitus and the relation to atherogenesis]. Felt V Vnitr Lek; 1986 Nov; 32(11):1066-72. PubMed ID: 3798773 [No Abstract] [Full Text] [Related]
5. [Activity of factor XIII and various lipid components of blood serum in patients with diabetes mellitus]. Zarzycka B; Pietruska Z; Kinalska I Pol Arch Med Wewn; 1987 Mar; 77(3):94-100. PubMed ID: 3275395 [No Abstract] [Full Text] [Related]
6. [Lowering of resistance to oxidation of VLDL lipoproteins and some subfractions of LDL lipoproteins in patients with non-insulin-dependent diabetes mellitus]. Ragino IuI; Dushkin MI; Nikitin IuP Ter Arkh; 1999; 71(4):52-5. PubMed ID: 10358865 [TBL] [Abstract][Full Text] [Related]
7. A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Xi S; Yin W; Wang Z; Kusunoki M; Lian X; Koike T; Fan J; Zhang Q Int J Exp Pathol; 2004 Oct; 85(4):223-31. PubMed ID: 15312127 [TBL] [Abstract][Full Text] [Related]
8. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies]. Sergienko AA Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186 [TBL] [Abstract][Full Text] [Related]
9. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus]. Lapotnikov VA; Moiseev SI Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876 [TBL] [Abstract][Full Text] [Related]
10. [Morphofunctional changes in the erythrocytes in diabetes mellitus]. Efimov AS; Pleshanov EV; Gogina IF Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498 [TBL] [Abstract][Full Text] [Related]
11. [The results of a comparative study of the lipid peroxidation processes and of the malondialdehyde level of the blood cells in patients with diabetic angiopathies and during insulin therapy]. Rud'ko IA; Balashova TS; Golega EN; Balabolkin MI; Kubatiev AA Ter Arkh; 1994; 66(10):27-9. PubMed ID: 7863440 [TBL] [Abstract][Full Text] [Related]
12. [Lipid composition of thrombocytes in diabetes mellitus depending on the degree of microangiopathy]. Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov VZ Probl Endokrinol (Mosk); 1987; 33(4):20-3. PubMed ID: 3658945 [TBL] [Abstract][Full Text] [Related]
13. [Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2]. Klebanova EM; Balabolkin MI; Kreminskaia VM; Smirnov LD Ter Arkh; 2006; 78(8):67-70. PubMed ID: 17078221 [TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051 [TBL] [Abstract][Full Text] [Related]
15. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus]. Syrkin AL; Azizova OA; Drinitsina SV; Solovi'eva NP; Frenkel' EE; Savchenkova AP; Kliuchnikova TI Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for atherosclerosis in female type II diabetic patients with incipient diabetic nephropathy. Tkác I; Molcányiová A; Takác M; Tkácová R; Tomoriova E Wien Klin Wochenschr; 1992; 104(17):531-4. PubMed ID: 1413813 [TBL] [Abstract][Full Text] [Related]
17. [Maternal serum lipid at 36-42 weeks' gestation and their relationship to newborn weight in pregnant women with gestational diabetes mellitus and type 1 and type 2 diabetes mellitus]. He B; Li SQ; Wang W; Han P Zhonghua Fu Chan Ke Za Zhi; 2004 Oct; 39(10):675-7. PubMed ID: 16144564 [TBL] [Abstract][Full Text] [Related]
18. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704 [TBL] [Abstract][Full Text] [Related]
19. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications. Shichiri M Intern Med; 1997 Feb; 36(2):144-7. PubMed ID: 9099605 [No Abstract] [Full Text] [Related]